TY - JOUR
T1 - How does the vaccine approval procedure affect COVID-19 vaccination intentions?
AU - Angerer, Silvia
AU - Glätzle-Rützler, Daniela
AU - Lergetporer, Philipp
AU - Rittmannsberger, Thomas
N1 - Publisher Copyright:
© 2023
PY - 2023/9
Y1 - 2023/9
N2 - People's willingness to vaccinate is critical to combating the COVID-19 pandemic. We devise a representative experiment to study how the design of the vaccine approval procedure affects trust in newly developed vaccines and consequently public attitudes towards vaccination. Compared to an Emergency Use Authorization, choosing the more thorough Conditional Marketing Authorization approval procedure increases vaccination intentions by 13 percentage points. The effects of the increased duration of the approval procedure are positive and significant only for Emergency Use Authorization. Treatment effects do not differ between relevant subgroups, such as respondents who had (did not have) COVID-19, or between vaccinated and unvaccinated respondents. Increased trust in the vaccine is the key mediator of treatment effects on vaccination intentions.
AB - People's willingness to vaccinate is critical to combating the COVID-19 pandemic. We devise a representative experiment to study how the design of the vaccine approval procedure affects trust in newly developed vaccines and consequently public attitudes towards vaccination. Compared to an Emergency Use Authorization, choosing the more thorough Conditional Marketing Authorization approval procedure increases vaccination intentions by 13 percentage points. The effects of the increased duration of the approval procedure are positive and significant only for Emergency Use Authorization. Treatment effects do not differ between relevant subgroups, such as respondents who had (did not have) COVID-19, or between vaccinated and unvaccinated respondents. Increased trust in the vaccine is the key mediator of treatment effects on vaccination intentions.
KW - Approval procedure
KW - COVID-19
KW - Experiment
KW - Vaccination
UR - http://www.scopus.com/inward/record.url?scp=85166218707&partnerID=8YFLogxK
U2 - 10.1016/j.euroecorev.2023.104504
DO - 10.1016/j.euroecorev.2023.104504
M3 - Article
AN - SCOPUS:85166218707
SN - 0014-2921
VL - 158
JO - European Economic Review
JF - European Economic Review
M1 - 104504
ER -